标题
Complex oncogene dependence in microRNA-125a-induced myeloproliferative neoplasms
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 109, Issue 41, Pages 16636-16641
出版商
Proceedings of the National Academy of Sciences
发表日期
2012-09-25
DOI
10.1073/pnas.1213196109
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A
- (2012) A. A. Chaudhuri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic screen identifies microRNA cluster 99b/let-7e/125a as a regulator of primitive hematopoietic cells
- (2011) A. Gerrits et al. BLOOD
- Eμ/miR-125b transgenic mice develop lethal B-cell malignancies
- (2011) Y Enomoto et al. LEUKEMIA
- MicroRNAs as therapeutic targets in cancer
- (2011) S. Patrick Nana-Sinkam et al. Translational Research
- Conserved Regulation of p53 Network Dosage by MicroRNA–125b Occurs through Evolving miRNA–Target Gene Pairs
- (2011) Minh T. N. Le et al. PLoS Genetics
- The prognostic and functional role of microRNAs in acute myeloid leukemia
- (2010) G. Marcucci et al. BLOOD
- Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
- (2010) Mark E. Hatley et al. CANCER CELL
- Functional screening using a microRNA virus library and microarrays: a new high-throughput assay to identify tumor-suppressive microRNAs
- (2010) Masashi Izumiya et al. CARCINOGENESIS
- A microRNA regulating adult hematopoietic stem cells
- (2010) Shangqin Guo et al. CELL CYCLE
- IDH1andIDH2Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- (2010) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- miRNAs in human cancer
- (2010) Thalia A Farazi et al. JOURNAL OF PATHOLOGY
- OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
- (2010) Pedro P. Medina et al. NATURE
- Selective activation of p53-mediated tumour suppression in high-grade tumours
- (2010) Melissa R. Junttila et al. NATURE
- Stage-specific sensitivity to p53 restoration during lung cancer progression
- (2010) David M. Feldser et al. NATURE
- MicroRNA miR-125b causes leukemia
- (2010) M. Bousquet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets
- (2010) A. G. L. Ooi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output
- (2010) R. M. O'Connell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA miR-125a controls hematopoietic stem cell number
- (2010) S. Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integration of cytokine and heterologous receptor signaling pathways
- (2009) Jelena S Bezbradica et al. NATURE IMMUNOLOGY
- Inositol phosphatase SHIP1 is a primary target of miR-155
- (2009) R. M. O'Connell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Myeloproliferative disorders
- (2008) R. L. Levine et al. BLOOD
- Oncogene Addiction
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- MicroRNA-Mediated Control of Cell Fate in Megakaryocyte-Erythrocyte Progenitors
- (2008) Jun Lu et al. DEVELOPMENTAL CELL
- Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation
- (2008) Marina Bousquet et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features
- (2008) A Orazi et al. LEUKEMIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started